Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 13Menorrhagia 4Myoma 3Myofibroma 3Infertility 2Polyps 1Pelvic Pain 1Hemorrhage 1Fibroma 1Dysmenorrhea 1Blood Loss, Surgical 1Agnosia 1

Interventions

Tranexamic Acid 13Sodium Chloride 4Misoprostol 4Saline Solution 3Enoxaparin 3carbetocin 2Tourniquets 2Ringer's Lactate 2Oxytocin 2Endoscopic Mucosal Resection 2Dalteparin 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Vitamin B 6 1Vasopressins 1Uterine Myomectomy 1Uterine Artery Embolization 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Solution 1Radiotherapy 1Proton Pump Inhibitors 1Palliative Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hemorrhage × Uterine Myomectomy × Clear all
NCT01328067 2018-06-15

Study to Evaluate the Safety and Effectiveness of MRgFUS Compared With Myomectomy for the Treatment of Uterine Fibroids

InSightec

Phase NA Withdrawn

Hemorrhage, Leiomyoma, Pelvic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡